Organon & Co.

OGN · NYSE · SIC 2834: Pharmaceutical Preparations
69
SEC Filings

Business Summary

PART I Overview Organon & Co. (Organon, the Company, we, our, or us) is a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. With a portfolio of over 70 products across womens health and general medicines, which includes biosimilars, Organon focuses on addressing health needs that uniquely, disproportionately or differently affect women, while expanding access to essential treatments in over 140 countries and territories. We sell thes...

Next Earnings

Q2 FY2026 — expected 2026-08-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionOGNdiscussed_in_filing Cybersecurity
topic_mentionOGNdiscussed_in_filing Blockchain & Crypto
topic_mentionOGNdiscussed_in_filing Sovereign & Government
topic_mentionOGNdiscussed_in_filing Cybersecurity
topic_mentionOGNdiscussed_in_filing Blockchain & Crypto
topic_mentionOGNdiscussed_in_filing Sovereign & Government
topic_mentionOGNdiscussed_in_filing Blockchain & Crypto
topic_mentionOGNdiscussed_in_filing Healthcare & Bio
topic_mentionOGNdiscussed_in_filing Sovereign & Government
topic_mentionOGNdiscussed_in_filing Blockchain & Crypto
topic_mentionOGNdiscussed_in_filing Healthcare & Bio
topic_mentionOGNdiscussed_in_filing Sovereign & Government

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-242025-12-310001628280-26-011125EDGAR75K words
2025-02-282024-12-310001821825-25-000006EDGAR—
2024-02-262023-12-310001628280-24-006733EDGAR—
2023-02-272022-12-310001821825-23-000003EDGAR—
2022-03-212021-12-310001821825-22-000002EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001628280-25-050795EDGAR26K words
2025-08-062025-06-300001821825-25-000066EDGAR—
2025-05-022025-03-310001821825-25-000023EDGAR—
2024-11-012024-09-300001821825-24-000108EDGAR—
2024-08-072024-06-300001821825-24-000083EDGAR—
2024-05-032024-03-310001821825-24-000056EDGAR—
2023-11-032023-09-300001821825-23-000013EDGAR—
2023-08-092023-06-300001821825-23-000010EDGAR—
2023-05-052023-03-310001821825-23-000006EDGAR—
2022-11-042022-09-300001821825-22-000012EDGAR—
2022-08-052022-06-300001821825-22-000009EDGAR—
2022-05-062022-03-310001821825-22-000006EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-200001104659-26-017870EDGAR1K words
2026-02-120001104659-26-013888EDGAR—
2025-11-100001104659-25-108821EDGAR—
2025-11-070001104659-25-108130EDGAR—
2025-10-270001104659-25-102324EDGAR—
2025-08-050001104659-25-073929EDGAR—
2025-06-120001104659-25-058900EDGAR—
2025-05-270001104659-25-052994EDGAR—
2025-05-010001104659-25-043023EDGAR—
2025-04-150001104659-25-035173EDGAR—

69 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001821825
TickerOGN
ExchangeNYSE
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: e3151d24456da5b57df85fac34a9593b3eca65fb52bd5b2fa78a305a5b44cce7
parent: 09b4e57eabdfa2ab2e94657a9e3dd29f82f09dabdb6d69b11b4286e69ef8f30d
content hash: 843b54a098d350004d25fcc59905377c08fd43960606902ba9bc6be505fd7730
signed: 2026-04-13T04:46:41.926Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf